IMPRESA SGPS SA (IPR.LS) Fundamental Analysis & Valuation

ELI:IPR • PTIPR0AM0000

Current stock price

0.187 EUR
0 (-2.35%)
Last:

This IPR.LS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IPR.LS Profitability Analysis

1.1 Basic Checks

  • In the past year IPR has reported negative net income.
  • In the past year IPR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: IPR reported negative net income in multiple years.
  • Each year in the past 5 years IPR had a positive operating cash flow.
IPR.LS Yearly Net Income VS EBIT VS OCF VS FCFIPR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

  • IPR's Return On Assets of -20.73% is on the low side compared to the rest of the industry. IPR is outperformed by 81.54% of its industry peers.
  • IPR's Return On Equity of -79.68% is on the low side compared to the rest of the industry. IPR is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
ROA -20.73%
ROE -79.68%
ROIC N/A
ROA(3y)-6.58%
ROA(5y)-2.74%
ROE(3y)-24.75%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
IPR.LS Yearly ROA, ROE, ROICIPR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 33.46%, IPR is doing worse than 66.15% of the companies in the same industry.
  • IPR's Gross Margin has declined in the last couple of years.
  • IPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
IPR.LS Yearly Profit, Operating, Gross MarginsIPR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. IPR.LS Health Analysis

2.1 Basic Checks

  • IPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IPR has about the same amout of shares outstanding than it did 1 year ago.
  • IPR has about the same amout of shares outstanding than it did 5 years ago.
  • IPR has a worse debt/assets ratio than last year.
IPR.LS Yearly Shares OutstandingIPR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
IPR.LS Yearly Total Debt VS Total AssetsIPR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • IPR has an Altman-Z score of -0.35. This is a bad value and indicates that IPR is not financially healthy and even has some risk of bankruptcy.
  • IPR has a worse Altman-Z score (-0.35) than 80.00% of its industry peers.
  • The Debt to FCF ratio of IPR is 15.65, which is on the high side as it means it would take IPR, 15.65 years of fcf income to pay off all of its debts.
  • IPR's Debt to FCF ratio of 15.65 is in line compared to the rest of the industry. IPR outperforms 43.08% of its industry peers.
  • A Debt/Equity ratio of 1.15 is on the high side and indicates that IPR has dependencies on debt financing.
  • The Debt to Equity ratio of IPR (1.15) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 15.65
Altman-Z -0.35
ROIC/WACCN/A
WACC5.34%
IPR.LS Yearly LT Debt VS Equity VS FCFIPR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.44 indicates that IPR may have some problems paying its short term obligations.
  • With a Current ratio value of 0.44, IPR is not doing good in the industry: 81.54% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.44 indicates that IPR may have some problems paying its short term obligations.
  • The Quick ratio of IPR (0.44) is worse than 81.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
IPR.LS Yearly Current Assets VS Current LiabilitesIPR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. IPR.LS Growth Analysis

3.1 Past

  • The earnings per share for IPR have decreased strongly by -2807.97% in the last year.
  • Looking at the last year, IPR shows a decrease in Revenue. The Revenue has decreased by -3.29% in the last year.
  • IPR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.34% yearly.
EPS 1Y (TTM)-2807.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.89%
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-1.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPR.LS Yearly Revenue VS EstimatesIPR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IPR.LS Yearly EPS VS EstimatesIPR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0.01 0.02 0.03 0.04 0.05

More info and screens

Find the best growth stocksShow best growing peers

2

4. IPR.LS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IPR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPR.LS Price Earnings VS Forward Price EarningsIPR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, IPR is valued cheaper than 95.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.23
EV/EBITDA N/A
IPR.LS Per share dataIPR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IPR.LS Dividend Analysis

5.1 Amount

  • No dividends for IPR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IPR.LS Fundamentals: All Metrics, Ratios and Statistics

IMPRESA SGPS SA

ELI:IPR (3/16/2026, 7:00:00 PM)

0.187

0 (-2.35%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-11
Earnings (Next)07-22
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap31.42M
Revenue(TTM)176.02M
Net Income(TTM)-67.42M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF 3.23
P/OCF 2.63
P/B 0.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY30.99%
OCF(TTM)0.07
OCFY37.97%
SpS1.05
BVpS0.5
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.73%
ROE -79.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.46%
FCFM 5.53%
ROA(3y)-6.58%
ROA(5y)-2.74%
ROE(3y)-24.75%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 15.65
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -0.35
F-Score4
WACC5.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2807.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-1.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-550.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.5%
OCF growth 3Y-57.59%
OCF growth 5Y-39.33%

IMPRESA SGPS SA / IPR.LS Fundamental Analysis FAQ

What is the fundamental rating for IPR stock?

ChartMill assigns a fundamental rating of 1 / 10 to IPR.LS.


What is the valuation status for IPR stock?

ChartMill assigns a valuation rating of 2 / 10 to IMPRESA SGPS SA (IPR.LS). This can be considered as Overvalued.


How profitable is IMPRESA SGPS SA (IPR.LS) stock?

IMPRESA SGPS SA (IPR.LS) has a profitability rating of 1 / 10.